Last update 31 May 2025

Nilvadipine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Nilvadipine (JP17/USAN/INN), ARC 029, ARC-029
+ [9]
Action
blockers
Mechanism
L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers)
Therapeutic Areas
Inactive Indication
Originator Organization
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
Japan (17 Jan 1989),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H19N3O6
InChIKeyFAIIFDPAEUKBEP-UHFFFAOYSA-N
CAS Registry75530-68-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
Japan
17 Jan 1989
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseasePhase 3
France
24 Apr 2013
Alzheimer DiseasePhase 3
Germany
24 Apr 2013
Alzheimer DiseasePhase 3
Greece
24 Apr 2013
Alzheimer DiseasePhase 3
Hungary
24 Apr 2013
Alzheimer DiseasePhase 3
Ireland
24 Apr 2013
Alzheimer DiseasePhase 3
Italy
24 Apr 2013
Alzheimer DiseasePhase 3
Netherlands
24 Apr 2013
Alzheimer DiseasePhase 3
Sweden
24 Apr 2013
Alzheimer DiseasePhase 3
United Kingdom
24 Apr 2013
Cardiovascular DiseasesClinical--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
511
xgdchpasyi(ogulvfakkt) = zdpxtkrmax ndejpfiklm (btubkeajgq, left)
-
01 Aug 2019
Phase 3
511
Placebo
juyeyilvkf(skegzctkep) = uqbocmkqmn jefyiabkca (nmbgybykik )
-
21 May 2019
Phase 3
511
zvmwewsbeo(yhtqtebewi) = oacpbigfyt qfrqqnubet (kssxbfdzlp, 8.09 - 10.73)
Negative
24 Sep 2018
Placebo
zvmwewsbeo(yhtqtebewi) = zxtbkttcqs qfrqqnubet (kssxbfdzlp, 8.33 - 10.93)
Not Applicable
-
9
sbtjaqhrss(trmggbicww) = weaiuynftx bfhzjztfgw (lsaeoitbmd )
-
01 Apr 2010
sbtjaqhrss(trmggbicww) = amebhyxjwi bfhzjztfgw (lsaeoitbmd )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free